MSB 3.42% $1.21 mesoblast limited

and that's another non Teva version. It is clear that there's a...

  1. 203 Posts.
    and that's another non Teva version. It is clear that there's a great deal of uncertainty out there re phase 3 and there is absolutely nothing from msb or teva to allay those concerns. Even something as simple as 'teva reconfirms its commitment to the msb phase 3 revascor trials' would suffice. But no - nothing. To suggest that Teva is trying to keep msb quiet? Glaxo etc would be monitoring every move of msb. I must respectfully disagree Vin. IMO, MSB may be great scientists, but they are appalling at investor relations. I hope in time to be proved wrong.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.21
Change
0.040(3.42%)
Mkt cap ! $1.381B
Open High Low Value Volume
$1.17 $1.22 $1.17 $5.683M 4.776M

Buyers (Bids)

No. Vol. Price($)
1 20000 $1.21
 

Sellers (Offers)

Price($) Vol. No.
$1.21 19746 3
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.